Navigation Links
SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the World's First Voice Recognition Drug Safety Application Prototype
Date:1/17/2013

JERUSALEM, January 17, 2013 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, has signed an agreement with INTOVISION PRODUCT DEVELOPMENT & DESIGN  to manufacturers the world's first voice recognition drug safety application  Prototype.

The development is expected to take 4 months at which time it will be demonstrated to the world's leading drug (and drug container) manufacturers.

A video demonstration of the product applications can be viewed at http://youtube/PEy9ygT6jaA.

SafeCode is the developer of the world's first patent-protected voice recognition technology used to confirm prescription medications prior to their administration at home or in a medical center.  

Using SafeCode technology, prescription medications stored in specially designed locked containers can only be accessed and administered once the caregiver or patient correctly announces the name of the drug.

The technology ensures that the appropriate medication is being administered, as mistakes have accounted for thousands of deaths in recent years.  Often, nurses, doctors or patients are not careful when giving or taking medications and much medication's packaging may look similar. SafeCode Technology prevents medication errors, and thereby reduces the risk of severe injury or accidental death.

"We are hopeful that a contract with a manufacturer will be signed in the coming weeks, enabling us to build our first product prototype," said Joel Klopfer , Chief Executive Officer of SafeCode Drug Technologies.  "There is a large addressable market for this technology due to the thousands of deaths each year related to medication errors."

About SafeCode Drug Techn
'/>"/>

SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
2. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
3. SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
4. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
5. UV Flu Technologies Outlines Distribution and Expansion Plans for 2013
6. Cumberland Emerging Technologies Expands Life Sciences Center
7. Blue Belt Technologies annonce que le Golden Jubilee National Hospital a réalisé la première opération NavioPFS darthroplastie unicondylaire du genou
8. Blue Belt Technologies Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery
9. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
10. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
11. Innovative CA Tumor Marker Tests Technologies and Emerging Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ) has ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... is a detailed type of imaging that customs a ... called a mammogram, is used to support in the ... An x-ray (radiograph) is a noninvasive medical test that ...
(Date:5/27/2015)... senior marketing associate with the animal health division of Eli Lilly and ... setting in Bangkok, Thailand , will be among the ... respect and dignity is the guiding star for me and my fellow ... LillyPad blog . Donatelli and Lilly colleagues from ... , France , Ukraine ...
(Date:5/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/9ffv95/2015_strategies ... "2015 Strategies in the European Coagulation Testing Market" ... comprehensive five-country report contains 500 pages, 120 tables, ... potential market entrants identify and evaluate business opportunities ... the next five years. The report ...
Breaking Medicine Technology:Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3European Coagulation Testing Market Strategies 2015 2
... of Having a Venous ThromboEmbolism (VTE) is Reduced ... Treated With,Clexane(R) / Lovenox(R), BRIDGEWATER, N.J., April 20, ... PREVAIL (Prevention,of VTE after Acute Ischemic Stroke with ... The Lancet. The results of the trial showed,that ...
... Ceragenix Pharmaceuticals,Inc. (OTCBB:CGXP), a biopharmaceutical company focused ... publication,of a research paper on two of ... paper appeared in the April issue,of the ... official Journal of the American Society of,Microbiology, ...
Cached Medicine Technology:The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 2The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 3The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 4The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 5The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 6Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4
(Date:5/27/2015)... 27, 2015 Khanna Vision Institute (KVI) announced ... portal focussed on keratoconus eye disease . Keratoconus is ... has its onset in the teenage years. It worsens over ... the front clear part of the eye is defective. It ... eye. It results in poor vision which cannot even be ...
(Date:5/27/2015)... New York (PRWEB) May 27, 2015 ... filed on behalf of individuals who allegedly ... related to the use of the antipsychotic drug ... litigation currently underway in Pennsylvania’s Philadelphia Court of ... is proceeding with its bellwether trial program, as ...
(Date:5/27/2015)... In today's healthcare landscape, where costs are ... challenging for doctors and hospitals to keep up with ... Austin-based HealthTronics, Inc. is offering a solution ... for clinically sophisticated applications. The company has now broadened ... Laser Ventures, Inc ., a mobile laser technology company ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), ... enterprise organizations, announced today that SanMar Corporation successfully ... time, attendance and point tracking processes for over ... States. , Family-owned since 1971, Seattle-based SanMar ... private label, and mill brands. SanMar supplies apparel ...
(Date:5/27/2015)... AR (PRWEB) May 27, 2015 ... today announce a partnership to provide CMSA's Career ... community. This collaboration seeks to strengthen the case/care ... through CMSA’s CKP program. The mutually beneficial agreement ... identifying individual skills of talent in the healthcare, ...
Breaking Medicine News(10 mins):Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... Mich. Scientists at the University of Michigan Comprehensive Cancer ... cancer stem cells, the small number of cells in a ... that breast cancer stem cells are regulated by a type ... These cells are drawn from the bone marrow to the ...
... Controlling blood pressure is not only a medical challenge, ... required to strictly adhere to a treatment plan that ... the ideas of wellness and health are also powerful ... This is especially true in the African American ...
... recent study by Merikangas and colleagues published in the ... American Academy of Child and Adolescent Psychiatry (JAACAP) ... with severely impairing mental disorders ever receive treatment for ... one third of adolescents with any mental disorder received ...
... Heart disease is the leading cause of death for ... disease is more than just one disease; there are many ... blood pressure, diabetes or other causes. In lipotoxic cardiomyopathy, for ... cells. Obesity and high-fat diets are major risk factors for ...
... According to the World Health Organisation (WHO), an estimated 322,000 ... fire and in many of these cases death could have ... intervention, when major burn patients have insufficient skin left to ... skin has literally to be grown from the patient,s own ...
... Reporter , MONDAY, Jan. 17 (HealthDay News) -- Few ... measure up, according to new research. Dermatologists evaluated ... from the sun,s ultraviolet rays and found only a ... can penetrate glass. "The vast majority of the ...
Cached Medicine News:Health News:U-M researchers find indirect path to attack breast cancer stem cells 2Health News:Storytelling may help control blood pressure in African-Americans 2Health News:Adolescents with severe mental disorders have never received treatment 2Health News:A different path to fat-related heart disease 2Health News:Nanotech medicine 2Health News:Nanotech medicine 3Health News:Nanotech medicine 4Health News:Despite Claims, Many Daily Moisturizers Don't Shield Against Sun: Study 2Health News:Despite Claims, Many Daily Moisturizers Don't Shield Against Sun: Study 3
... depurinated DNA and RNA from agarose gels ... 15 minutes ,Increases speed and efficiency of ... applied to gel ,Part of an integrated ... UV crosslinking in 2.5 hours, versus 29 ...
PosiBlot 30-30 Pads...
A blotter fit for use with the incredible new Criterion precast gel system, the Criterion blotter combines excellent blotting efficiency with the flexibility of the Trans-Blot system and the ease-of-...
... High resolution ,transfer of DNA and RNA ... downward capillary transfer allows for,alkaline buffer transfers ... in three hours. , Economical ... blotting paper. Convenient refill packs available., ...
Medicine Products: